Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Randomised Double-Blind Placebo-Controlled Crossover Study of Mexiletine in Non-Dystrophic Myotonia
2009-011184-36Phase 2Completed
- Sponsor
- University College London
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of mexiletine in non-dystrophic myotonia (NDM) and muscle diseases (NMD) (2 arms), sponsored by University College London. Primary endpoint: Mean patient-assessed stiffness via IVR diary. Started May 2009; status: completed.
02
Drugs
mexiletine
03
Conditions
non-dystrophic myotonia (NDM)muscle diseases (NMD)
Beyond the preview
Go deeper on 2009-011184-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011184-36.